Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL

Aim:  The aim of this study was to evaluate the prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhotic patients with fasting plasma glucose (FPG) level of <126 mg/dL.

[1]  Yoshiyuki Suzuki,et al.  Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients. , 2010, The American journal of medicine.

[2]  R. Malek,et al.  Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. , 2010, World journal of gastroenterology.

[3]  M. Shimizu,et al.  Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus‐positive patients: A prospective, case series study , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  Yoshiyuki Suzuki,et al.  Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C , 2009, Hepatology.

[5]  D. García-Compeán,et al.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. , 2009, World journal of gastroenterology.

[6]  Yoshiyuki Suzuki,et al.  Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  M. Koga,et al.  CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. , 2008, Diabetes research and clinical practice.

[8]  M. Manns,et al.  Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus , 2008, Hepatology.

[9]  F. Mehboob,et al.  HEPATITIS C PATIENTS; , 2008, The Professional Medical Journal.

[10]  O. Yokosuka,et al.  Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus‐infected and hepatitis C virus‐cleared patients , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[11]  N. Hayashi,et al.  Oral Glucose Tolerance Test Predicts Prognosis of Patients with Liver Cirrhosis , 2006, The American Journal of Gastroenterology.

[12]  H. El‐Serag,et al.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.

[13]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[14]  K. Murase,et al.  Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus , 2003, Journal of Gastroenterology.

[15]  A. Carroccio,et al.  Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. , 2001, Diabetes & metabolism.

[16]  B. Tom,et al.  Further evidence for an association between non–insulin‐dependent diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[17]  N. Turkçapar,et al.  Association of diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[18]  A. Andriulli,et al.  HCV and diabetes mellitus: evidence for a negative association , 1998, American Journal of Gastroenterology.

[19]  Brouwer,et al.  glycyrrhizin as a potential treatment for chronic hepatitis C , 1998, Alimentary pharmacology & therapeutics.

[20]  Richard E. Sampliner,et al.  The Natural History of Community-Acquired Hepatitis C in the United States , 1993 .

[21]  K. Chayama,et al.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.

[22]  H. Tsukuma,et al.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.

[23]  K. Kiyosawa,et al.  Review of hepatitis C in Japan , 1991, Journal of gastroenterology and hepatology.

[24]  E. Schiff,et al.  Hepatitis C–associated hepatocellular carcinoma , 1990, Hepatology.

[25]  M. Houghton,et al.  Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma , 1990, The Lancet.

[26]  M. Houghton,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA , 1989, The Lancet.

[27]  Williams Jt,et al.  ROYAL COLLEGE OF PHYSICIANS. THE NEW BUILDING. , 1964, Lancet.

[28]  D. García-Compeán,et al.  The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. , 2011, Annals of hepatology.

[29]  今井 健二.  Insulin resistance raises the risk for recurrence of stage 1 hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients : a prospective, case series study , 2009 .

[30]  R. D. de Man,et al.  Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. , 1998, Alimentary pharmacology & therapeutics.

[31]  I. M. Vertkin,et al.  Risk Factors , 2007, Annals of Internal Medicine.

[32]  N. L. Johnson,et al.  Multivariate Analysis , 1958, Nature.